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Background Accurate clinical problem lists are critical
for patient care, clinical decision support, population
reporting, quality improvement, and research. However,
problem lists are often incomplete or out of date.
Objective To determine whether a clinical alerting
system, which uses inference rules to notify providers of
undocumented problems, improves problem list
documentation.
Study Design and Methods Inference rules for 17
conditions were constructed and an electronic health
record-based intervention was evaluated to improve
problem documentation. A cluster randomized trial was
conducted of 11 participating clinics afﬁliated with
a large academic medical center, totaling 28 primary
care clinical areas, with 14 receiving the intervention and
14 as controls. The intervention was a clinical alert
directed to the provider that suggested adding a problem
to the electronic problem list based on inference rules.
The primary outcome measure was acceptance of the
alert. The number of study problems added in each arm
as a pre-speciﬁed secondary outcome was also
assessed. Data were collected during 6-month
pre-intervention (11/2009e5/2010) and intervention
(5/2010e11/2010) periods.
Results 17043 alerts were presented, of which 41.1%
were accepted. In the intervention arm, providers
documented signiﬁcantly more study problems (adjusted
OR¼3.4, p<0.001), with an absolute difference of 6277
additional problems. In the intervention group, 70.4% of
all study problems were added via the problem list alerts.
Signiﬁcant increases in problem notation were observed
for 13 of 17 conditions.
Conclusion Problem inference alerts signiﬁcantly
increase notation of important patient problems in
primary care, which in turn has the potential to facilitate
quality improvement.
Trial Registration ClinicalTrials.gov: NCT01105923.
INTRODUCTION AND BACKGROUND
An accurate and up-to-date patient problem list
represents the cornerstone of the problem-oriented
medical record, especially in internal medicine. It
serves as a valuable tool for providers attempting
to familiarize themselves with a patient’s clinical
status and provides a means of succinctly commu-
nicating this information between providers. In
addition, an accurate problem list has been associ-
ated with higher-quality care.
1 For example,
Hartung et al found that patients with ‘congestive
heart failure’ (CHF) on their problem list were more
likely to receive ACE inhibitors or angiotensin-II
receptor blockers than CHF patients without ‘CHF’
listed on their problem list. Further, many clinical
decision support (CDS) rules use problem list
entries to make inferences about patients,
2 so
a complete, accurate list may facilitate more effec-
tive CDS. Conversely, an incomplete or inaccurate
problem list could lead to delayed or inappropriate
care. Finally, an accurate and comprehensive
problem list would help to correctly identify patient
populations and create patient registries conduction
of quality improvement activities and research.
Despite these numerous beneﬁts, problems lists
are often inaccurate, incomplete, and out of
date.
3e5 In previous research, we showed that
problem list completeness in one network ranged
from 4.7% for renal insufﬁciency or failure to
50.7% for hypertension, 61.9% for diabetes, to a
maximum of 78.5% for breast cancer,
6 and other
institutions have found similar results.
3e5 In addi-
tion, we have found in previous qualitative studies
that provider attitudes toward, and use of, the
problem list vary widely.
78
Beginning in 2011, in order to be considered
‘meaningful users’ of an electronic health record
(EHR) and qualify to receive federal stimulus
grants under the HITECH Act, which can total US
$44000 through Medicare and US$63750 through
Medicaid, providers must, among other things,
‘maintain an up-to-date problem list of current and
active diagnoses,’ with 80% of patients having at
least one problem recorded or an indication of ‘no
known problems.’
9e11 Given wide variation in
problem list use by providers,
78new tools are
needed to help providers meet this goal.
Researchers have used a variety of strategies in an
attempt to detect patient problems and increase
problem list use. In general, these methods fall into
two broad categories: problem inference (or proxy)
rules and natural language processing (NLP) tech-
niques. Problem inference techniques use related
clinical information such as laboratory tests,
medications, and billing codes to infer problems (eg,
a patient receiving metformin who has had
multiple abnormal HbA1c tests is likely to have
diabetes). In contrast, NLP strategies use algorithms
designed to process and code free-text entries such
as progress notes. Several groups have used data
mining techniques and clinical associations to
< An additional appendix is
published online only. To view
this ﬁle please visit the journal
online (www.jamia.bmj.com/
content/19/4.toc).
1Division of General Internal







4Department of Health Policy
and Management, Harvard
School of Public Health, Boston,
Massachusetts, USA
Correspondence to
Dr Adam Wright, Brigham and
Women’s Hospital, 1620
Tremont St, Boston, MA 02115,
USA; awright5@partners.org
Received 2 August 2011
Accepted 5 December 2011
Published Online First
3 January 2012
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://
jamia.bmj.com/site/about/
unlocked.xhtml
J Am Med Inform Assoc 2012;19:555e561. doi:10.1136/amiajnl-2011-000521 555
Research and applicationspredict patient problems.
12e14 Others have reported success
using NLP techniques to automate the problem list.
15e17 Prior
efforts have generally been evaluated in a laboratory setting, and
focused on a single or small number of problems.
In this study, we performed a cluster randomized, controlled
trial of a clinical alerting system that used inference rules to
detect and notify providers of undocumented problems, giving
them the opportunity to correct these gaps and increase problem
list completeness. Our goal was to assess whether or not this




In a prior study, we presented a novel method for developing and
validating problem-inference rules,
6 as well as a knowledge base
containing validated rules for 17 clinically important conditions
(henceforth referred to as ‘study problems’). These rules were
based on previous work using data-mining techniques to iden-
tify medication-problem associations and laboratory-problem
associations.
14 The rules take into account problem list entries
(free-text and coded), billing diagnosis codes, laboratory results,
medications, and vital signs to identify likely gaps in the
problem list. Rule development and validation is described in
detail in our previous work.
6 To summarize, rule development
occurred in six steps: (1) identiﬁcation of problem associations
with structured data; (2) selection of speciﬁc problems; (3)
development of preliminary rules; (4) characterization of
preliminary rules and alternatives; (5) selection of a ﬁnal rule;
and (6) validation of the ﬁnal rule. Using these rules, the average
sensitivity and positive predictive value (PPV) for the training
set were 83.4% and 91.1%, respectively; for the validation set,
average sensitivity and PPV were comparable at 83.9% and
91.7%, respectively. Importantly, the inference rules were more
sensitive than the problem list itself and had a higher PPV than
billing codes. The performance of the rules is fully described
in our prior paper,
6 and the contents of the rules are presented
in the online appendix. As we developed the rules, we prio-
ritized PPVand speciﬁcity in order to minimize the occurrence of
false positive alerts, which might annoy users; however, for
most conditions, we were able to achieve good performance on
all four metrics: PPV, negative predictive value, speciﬁcity and
sensitivity.
In four cases, we developed rules for groups of clinically
similar entities: asthma/chronic obstructive pulmonary disease
(COPD), congenital coagulopathy (hemophilia, congenital factor
XI deﬁciency and von Willebrand disorder), osteoporosis/osteo-
penia, and renal failure/insufﬁciency. We created these groupings
because, although we were able to determine, with a high degree
of certainty, that the patient had one of the conditions (eg,
asthma or COPD), we could not reliably discriminate between
the conditions because of similar diagnostic criteria or treatment
approaches. The 17 rules developed were:
< Attention deﬁcit hyperactivity disorder
< Asthma/COPD
< Breast cancer
< Coronary artery disease (CAD)
< Congenital coagulopathy (hemophilia, congenital factor XI











< Sickle cell disease
< Stroke
For each condition, problem synonyms were identiﬁed (eg,
diabetes mellitus, type 2 diabetes, non-insulin-dependent dia-
betes mellitus). The alert would only ﬁre if neither the problem
itself nor any synonyms were present on the patient’s problem
list. However, hierarchically related problems did not cause
suppression of the alert (eg, hyperglycemia on the problem list
did not prevent the diabetes mellitus alert from displaying, nor
did nephropathy prevent renal insufﬁciency from being
suggested). The complete set of rules for the study problems is
described in detail in the online appendix, which uses standard
codes (LOINC, SNOMED and ICD-9) to maximize its useful-
ness to sites wishing to replicate our study. The longitudinal
medical record (LMR), a proprietary, full-featured, outpatient
EHR
18 uses proprietary codes for laboratory results and prob-
lems, and our internal rules used these codes. However, the
proprietary code systems are directly mapped to LOINC and
SNOMED, respectively, and we used these pre-existing
mappings to create the online appendix, so the description of the
rules in the appendix matches the internal logic of our system
exactly.
Setting and participants
Participating clinics (n¼11) included all primary care practices
afﬁliated with Brigham and Women’s Hospital, an academic
medical center in Boston, Massachusetts. Each practice used the
LMR, which allows providers to record patient problems on an
electronic problem list from a database of coded problems or as
free-text entries. Participating clinics were divided into a total of
28 ‘clinical areas’ based on pre-existing administrative divisions
within the clinics (eg, suites A, B, and C or pediatric vs adult
medicine).
Participating practices included both urban and suburban
clinics and a diverse mixture of primary care clinics in hospital
and community settings across the greater-Boston area. These
practices serve a racially and socioeconomically diverse
population of patients.
Randomization and interventions
We developed an electronic alert in the LMR which notiﬁes
providers when there appears to be an undocumented problem.
At the time, a provider saves a typed note or reviews a dicta-
tion, and our system analyzes the patient’s medications, labo-
ratory results, billing codes, and vital signs and uses the
knowledge base to determine whether a patient is likely to
have any of the 17 study problems. If the system detects one or
more potential problems, it reviews the problem list to deter-
mine whether the problem is documented, and, if not, an
actionable alert is shown onscreen (ﬁgure 1). If more than one
undocumented problem is detected, alerts for all undocumented
problems are displayed in a single window. To the right of each
suggested problem is a reason why the alert is appearing. To
the left is a check-box, which providers can use to select
problems to add. Problems are ‘pre-checked’ for ease-of-use.
Providers can accept the alert (in which case the problem will
be added to the problem list), ignore the alert (in which case it
will be presented the next time a note is completed for that
patient), or over-ride the alert (in which case the alert is
556 J Am Med Inform Assoc 2012;19:555e561. doi:10.1136/amiajnl-2011-000521
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adds a problem, he or she is also given the opportunity to
add additional details or select a related term (eg, ‘gestational
diabetes’ or ‘diabetes mellitus type 2’ instead of simply
‘diabetes mellitus’).
We conducted a randomized controlled trial of this interven-
tion for a 6-month period, and also collected baseline data before
the intervention in order to provide a second control. To reduce
the risk of contamination, we used a cluster randomization
method.
Clusters (n¼28) were designated on the basis of pre-existing
administrative divisions within the clinics. For example, one
primary care clinic is divided into adult medicine, family medi-
cine, and pediatric medicine, and another is divided into separate
suites, A, B, and C. In both cases, these subunits were treated as
separate clusters. Clusters were then grouped into three bands:
hospital-based, community and federally qualiﬁed health center.
Once grouped into the three bands, the clusters within each
band were randomly allocated to the control or intervention
arms, with 14 clinics randomized to the control arm and 14 to
the intervention arm.
Providers were not aware to which arm their subclinic group
was assigned until the intervention was implemented. Patients
were not made aware of the intervention. No pre-intervention
orientation or training took place in the intervention arm.
Blinding was not possible given the nature of this intervention.
Data were collected over a 6-month pre-intervention period and
a subsequent 6-month intervention period. The system went
live on May 16, 2010 in the intervention group clinics, and
post-period data were collected prospectively for 183 days
(6 months) for both arms, concluding on November 14, 2010. In
addition, 183 days (6 months) of pre-period data from both
arms were collected retrospectively to act as a baseline. The
study was approved by the Partners HealthCare Human
Research Committee and was registered with ClinicalTrials.gov
(NCT01105923).
Outcomes and follow-up
The primary outcome of this study was the acceptance rate of
the alert, deﬁned as number of alerts accepted divided by
number of unique alerts presented. In certain instances,
providers might see the same alert serially, so we aggregated
presentations and acceptances of the same alert for the same
patients in our calculation of the acceptance rate.
As a secondary outcome, we measured the number of study
problems documented in the two groups during the two time
periods, and calculated the unadjusted relative rate of problem
notation in the intervention group by comparing the number of
problems recorded in the intervention arm during the interven-
tion period to all other groups. The unadjusted relative rate was
deﬁned as the ratio (problemsintervention-post/problemscontrol-post)/
(problemsintervention-pre/problemscontrol-pre).
Statistical analysis
For the primary outcome, we calculated the acceptance rate of
the alert for each of the 17 conditions, as well as an overall
acceptance rate. For the secondary outcome of problem addition,
which consisted of comparisons of count data, we modeled our
data as Poisson-distributed counts. The unadjusted relative rate
was calculated as described above, and tested for equality with
one using a normal approximation.
In addition to this unadjusted relative rate, we used Poisson
regression with an interrupted time series approach to control
for potential exogenous temporal effects. Speciﬁcally, we used
ﬁve coefﬁcients and a scale parameter to model six features:
starting rate, four slopes (pre and post period for the control and
intervention arms), and a parameter for effect of the interven-
tion. The effect parameter was an OR for the immediate effect
of the intervention. In the case where differences between the
control and intervention groups were non-signiﬁcant, we
removed the related terms from our model. This resulted in
a new parameter for the intervention, which instead measured
the overall effect of the intervention. This parameter has
a similar interpretation to our unadjusted relative rate, and was
compared for equality with one using a c
2 test.
Finally, in order to counteract a possible problem of multiple
comparisons, we used a Bonferroni correction. This correction
maintains the error rate by testing each hypothesis against
a lower a value, where the new cut-off for statistical signiﬁcance
is a/n, where n is the number of independent tests. In our case,
the new cut-off was calculated to be 0.0029 (0.05/17 rules).
Demographic data were analyzed using a c
2 test for categor-
ical data and Student t test for continuous variables. Study data
were analyzed using SAS V.9.2.
Figure 1 Screenshot of problem
inference alerts.
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RESULTS
Participant ﬂow
All 28 participating clinics completed the study, and there was
no loss to follow-up. Overall, 41039 patients were seen in the
control clinics during the entire study period, and 38025
patients were seen in the intervention clinics. A small number of
patients (n¼3894, 5.2%) were seen in both intervention and
control clinics, and thus appear in both arms of the study.
Figure 2 shows the ﬂow of subclinics through the study.
Demographic and baseline data
Intervention and control groups appeared clinically similar
across a range of demographic and clinical variables (table 1).
During the 6-month pre-intervention period, greater problem list
use was observed in the control group. A total of 3230 study
problems (17.8 problems/day) were added in the intervention
group, and 3597 study problems (19.8 problems/day) were added
in the control group (p<0.001).
Primary outcome: acceptance rate
Problem inference rules ﬁred a total of 17043 times during the
intervention period for a total of 11508 patients in the inter-
vention arm. The overall acceptance rate for problem inference
alerts was 41.1%. The highest acceptance rate of the 17 condi-
tions was 55.7% for glaucoma alerts (table 2). Alerts for myas-
thenia gravis and sickle cell disease were infrequently presented
and infrequently accepted.
Pre-speciﬁed secondary outcome: problem notation in the
problem list
During the intervention period, 10016 study problems were
added in the intervention group compared with 3739 added in
the control groupdan absolute difference of 6277 problems
(compared with 367 fewer problems added in the intervention
group during the pre-intervention period, p<0.0001). The
unadjusted relative rate of study problem addition was 2.98
times more problem notation in the intervention group
(p<0.0001), and the adjusted OR was 3.43 (p<0.0001).
The cumulative number of study problems added over the
course of the entire study is shown in ﬁgure 3. As reﬂected in the
ﬁgure, the rate of study problem notation during the pre-inter-
vention period was slightly lower in the intervention group than
in the control group. The inﬂection point in the intervention
group line was coincident with the initiation of the study
intervention in that group and, by the completion of the study,
the intervention group had added signiﬁcantly more problems
than the control group.
Table 3 shows the rate of problem list addition for each of the
17 study problems. Using the unadjusted differences measure,
statistically signiﬁcant increases in problem notation were seen
for 15 of 17 study problems using an uncorrected threshold of
p<0.05. When the Bonferroni correction was applied to the
threshold, two of the 15 problems were no longer statistically
signiﬁcant (congenital coagulopathy and hyperthyroidism).
Relative rates of problem notation (for statistically signiﬁcant
conditions) ranged from 1.54 times more notation for hyper-
thyroidism (p¼0.031) to 6.89 times more notation for renal
failure and insufﬁciency (p<0.0001).
In addition to the unadjusted difference, we used Poisson
regression and interrupted time series analysis to control for
temporal trends. We began with a model with four slopes
(results not shown). Outcomes from this model were similar to
Figure 2 Participant ﬂow for study clusters (subclinic randomization).
Because randomization was carried out at the subclinical level, a small
number of patients (n¼3849) appear in both arms of the study.
Table 1 Demographics of patients seen in control and intervention
clinics
Demographic characteristic Control Intervention p Value
Age (years), mean (SD) 49.6 (20.0) 47.7 (19.6) <0.0001
Sex (female) 61.4% 68.0% <0.0001
Race or ethnicity
American Indian 0.12% 0.17% <0.0001











Commercial 59.6% 64.1% <0.0001
Medicare 22.3% 17.7%
Medicaid 14.0% 14.6%
Other/self pay 4.0% 3.6%
Income (US$), mean (SD) 56350 (20686) 59663 (23737) <0.0001
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coagulopathy and hyperthyroidism were no longer statistically
signiﬁcant (at either p<0.05 or the Bonferroni-corrected
threshold of p<0.0029). After removal of non-signiﬁcant model
components (yielding a simpliﬁed two-slope model shown on
the right-hand side of table 3), the difference for congenital
coagulopathy was once again statistically signiﬁcant; however,
when the Bonferroni correction was used, this study problem
was not statistically signiﬁcant. ORs from the ﬁnal model were
mostly similar to the unadjusted relative rates, and the overall
OR for intervention effect on problem list notation was 3.43
(p<0.0001).
To assess the accuracy of problems added as the result of the
intervention, we also conducted an audit of a random selection
of accepted alerts (n¼1178). In order to form a representative
sample, we used a weighting strategy. Each of the 17 may have
been suggested on the basis of one or more condition sets (eg,
a diabetes suggestion could be triggered by the HbA1c value,
medications, billing codes, or a combination of these features).
For each condition set, we reviewed the accuracy of up to 30
alerts (less if there were fewer than 30 total accepted alerts for
a given condition set). Study staff (FM) conducted a manual
chart review, including a review of the notes. The gold standard
was free-text documentation of the problem in any stored
physician notes. We computed a weighted accuracy score by
taking the accuracy for each condition set and weighting it
according to how often that condition set triggered an alert. The
weighted accuracy of all accepted alerts was found to be 89.8%.
The 10.2% of alert acceptances not associated with documen-
tation had a variety of causes, including patients near to diag-
nosis of a disease (eg, patients with pre-diabetes or metabolic
syndrome on the cusp of diagnosis with diabetes), patients who
appeared to actually meet diagnostic criteria for the disease, but
for whom the diagnosis was not discussed in the record (eg,
patients who met diagnostic criteria for chronic kidney disease
based on glomerular ﬁltration rate or hypertension based
on serial blood pressure measures but without documentation
of the condition in their notes), as well as some potentially
erroneous additions.
DISCUSSION
We found that electronic problem list alerts were often accepted
by users, and resulted in a substantial increase in study problem
notation. The rate of notation of study problems increased
dramatically during the intervention period as a result of this
simple alert-based intervention. Overall, study problems were
approximately three times more likely to be documented when
alerts were shown. This increase is clinically important, since
many of these problems are used for quality improvement
and CDS.
Importantly, 14 out of 17 study problems were more often
recorded in the intervention group than the control group. Only
three conditions, myasthenia gravis, sickle cell disease, and
hyperthyroidism, had similar rates between the two groups;
however, even though the difference for hyperthyroidism was
not statistically signiﬁcant with Bonferroni correction, one could
infer that there may be a trend for possible statistical signiﬁ-
cance with a larger sample size. Since our previous research
validated the algorithm for the study problems,
6 it is probable












Attention deﬁcit hyperactivity disorder 225 102 31 194 45.3
Asthma/chronic obstructive pulmonary
disease
2452 842 585 1867 34.3
Breast cancer 245 116 36 209 47.3
Coronary artery disease 1069 439 274 795 41.1
Congenital coagulopathy 45 15 19 26 33.3
Congestive heart failure 914 331 279 635 36.2
Diabetes mellitus 1330 519 324 1006 39.0
Glaucoma 336 187 40 296 55.7
Hypertension 5362 2281 1029 4333 42.5
Hyperthyroidism 141 46 39 102 32.6
Hypothyroidism 1291 639 220 1071 49.5
Myasthenia gravis 15 3 6 9 20.0
Osteoporosis/osteopenia 2285 962 475 1810 42.1
Rheumatoid arthritis 231 61 78 153 26.4
Renal failure/insufﬁciency 991 413 148 843 41.7
Sickle cell disease 12 1 7 5 8.3
Stroke 99 54 14 85 54.5
Total 17043 7011 3604 13439 41.1
*Overall acceptance rate combines alerts that were accepted after being displayed multiple times (number of alerts accepted/unique rule ﬁrings).
Figure 3 Cumulative number of study problems added during pre-
intervention and intervention periods.
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cell disease is responsible for the lack of any difference in
notation between study arms.
Our results suggest that problem inference rules such as these
are a valuable tool for improving problem list completeness and
thus may be beneﬁcial for improving patient care. A more
complete problem list makes it easier for providers to obtain an
accurate picture of a patient’s issues, which is especially
important when an unfamiliar patient is being seen, such as in
the case of urgent care or emergency visits, or in inpatient wards.
Additionally, since problems are used for CDS, identiﬁcation of
patients for research studies, and quality measurement, these
types of rules show great potential for improving quality and
reducing costs.
One important question is how the observed increase in the
notation of problems would ultimately beneﬁt patients.
Assuming that a given alert was correct, there were two
potential scenarios for each alert reminder: (1) the alert called
attention to an undocumented problem that the provider was
not aware of and (2) the alert recommended a problem that the
provider was aware of but had not documented in the problem
list. Although the ﬁrst scenario may provide a particular
immediate clinical impact (making the provider aware of an
unknown diagnosis), it is also likely to be less common.
However, both cases provide signiﬁcant positive clinical beneﬁt,
including enabling CDS (such as relevant preventive care
reminders), facilitating quality measurement and research, and
promoting awareness of a patient’s active problems among the
entire care team (including providers that may not know the
patient well).
An additional implication of this study may be to help
providers achieve ‘meaningful use’ of EHRs, as one of the stage 1
and 2 meaningful use goals is to demonstrate problem list use for
80% of patients over the next few years.
9 10 By meeting the
meaningful use criteria, clinicians would receive incentive funds
that could offset the expenses of implementing and maintaining
the LMR. A tool such as that described here may be highly
valuable for encouraging problem list use and increasing
accuracy in the near term, especially for the large numbers of
providers who are just starting with electronic records and are
struggling to populate their problem lists.
Given these promising results and diverse potential applica-
tions, we hope to dramatically expand the problem inference
knowledge base in the future. Ultimately, rules such as these
may be used in tandem with provider documentation to increase
the accuracy of the problem list, with the potential to improve
patient care. However, additional provider engagement will also
be required, and some problem list maintenance tasks (such as
the removal of resolved problems or consolidation of duplicates)
are beyond the scope of our described intervention.
Limitations
Our investigation has several potential limitations. First,
problem inference rules were developed, validated, and tested at
a single site. Further research will need to be carried out to assess
the generalizability of these results. Additionally, we had the
beneﬁt of a self-developed EHR, giving us the ability to extract
the necessary data to develop and validate our knowledge base,
as well as the ability to design a novel intervention. In contrast,
most institutions use commercial EHR systems, which may not
have this degree of ﬂexibility. Although we encourage other
institutions to develop and validate their own rules when
feasible, we have also made our full knowledge base freely
available for use by other organizations, including vendors.
6
Another possible limitation of this approach is that imperfect
accuracy of the problem inference rules could lead to erroneous
alerts, which, if accepted, would result in inaccurate problems
being added to the problem list. An audit of a random selection
of accepted alerts revealed a global weighted accuracy of 89.8%.
Although the accuracy of accepted alerts was very high overall,
this ﬁnding nevertheless reveals the presence of a number of
problems erroneously added to the problem list as a result of the
alerts. Many of these instances appeared to be the result of
borderline conditions (eg, metabolic syndrome, white-coat
hypertension). However, the potential problem of providers
accepting erroneous clinical alerts merits further study.
Table 3 Total study problems recorded during pre-intervention and intervention periods with unadjusted and adjusted ORs
Problem
Pre-intervention period Intervention period Unadjusted* comparison
Adjustedy
comparison
Control Intervention Control Intervention Relative rate p Value OR p Value
Attention deﬁcit hyperactivity disorder 66 72 69 157 2.09 <0.0001 2.23 <0.0001
Asthma/chronic obstructive pulmonary
disease
498 503 529 1291 2.42 <0.0001 2.98 <0.0001
Breast cancer 151 123 180 246 1.68 0.0004 1.78 <0.0001
Coronary artery disease 164 134 178 576 3.96 <0.0001 4.66 <0.0001
Congenital coagulopathy 4 4 5 19 3.80 0.0133 2.06 0.0384
Congestive heart failure 64 50 97 373 4.92 <0.0001 7.56 <0.0001
Diabetes mellitus 597 446 535 814 2.04 <0.0001 1.97 <0.0001
Glaucoma 53 74 61 263 3.09 <0.0001 3.78 <0.0001
Hypertension 1019 863 1031 3082 3.53 <0.0001 4.12 <0.0001
Hyperthyroidism 86 96 72 124 1.54 0.0308 1.30 0.2928
Hypothyroidism 207 237 205 823 3.51 <0.0001 3.99 <0.0001
Myasthenia gravis 4 2 3 5 3.33 0.2850 2.10 0.114
Osteoporosis/osteopenia 513 483 582 1521 2.78 <0.0001 3.40 <0.0001
Rheumatoid arthritis 27 21 24 75 4.02 <0.0001 3.97 <0.0001
Renal failure/insufﬁciency 84 73 87 521 6.89 <0.0001 8.22 <0.0001
Sickle cell disease 9 12 13 23 1.33 0.3538 1.66 0.2897
Stroke 51 37 68 103 2.09 0.0023 2.35 0.0002
Total 3597 3230 3739 10016 2.98 <0.0001 3.43 <0.0001
*Unadjusted comparison based on unadjusted relative rate of problem list addition, as described in the methods sections.
yAdjusted comparison based on Poisson regression model for an interrupted time series.
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41.1%, with the rest of the alerts being either over-ridden or
ignored by physicians. Since the accuracy of the accepted alerts
was shown to be high in the above-described audit, future
research should look into the reasons why alerts are either over-
ridden or ignored. Finally, the intervention was limited to
primary care providers; extending this tool to specialties may
require more focus on the types of alerts presented.
CONCLUSION
Problem inference alerts appear to be a powerful tool for
improving notation of patient problems, and may thus in turn
help improve quality of care. The use of problem inference alerts
dramatically increased the notation of patient problems in the
intervention group. Healthcare providers seeking to increase
problem list completeness for meaningful use or other reasons
should consider implementing such alerts. Future studies should
focus on whether implementing such alerts has a direct effect on
patient outcomes.
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